(1R,1'R)-2,2'-(3,11-Dioxo-4,10-dioxatridecamethylene)-bis-(1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquindline)-dioxalate (96687-52-4)

Identification
Name:	(1R,1'R)-2,2'-(3,11-Dioxo-4,10-dioxatridecamethylene)-bis-(1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquindline)-dioxalate
Synonyms:	(1R,1R)-2,2-(3,11-Dioxo-4,10-dioxatridecamethylene)-bis-(1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquindline)-dioxalate;Intermediate of Cisatracurium Besylate;Maleicbenzeneakumaamine atracurium intermediates;
CAS:	96687-52-4
EINECS:	264-741-3
Molecular Formula:	C₅₁H₆₆N₂O₁₂^.2(C₂H₂O₄)
Molecular Weight:	1079.16
Molecular Structure:
Properties
Safety Data

Other Product

Spiro[2-cyclohexene-1,2'(1'H)-cyclopenta[de]naphthacene]-9'-carboxamide,7',7'a,8',11',11'a,12'-hexahydro-5',6',7'a,10',11'a,12'-hexahydroxy-3'-methoxy-2,6,6-trimethyl-7',8'-dioxo-,(1R,7'aR,11'aR,12'R)-rel-(-)-
Benzoic acid,2,4-dihydroxy-6-methyl-,(1'R,2'aR,4'R,4'aR,7R,7'S,9'aR,9'bR,11'aR)-3-[(1E)-2-carboxyethenyl]-1',2',2'a,3',4'a,6',7,7',8,8',9',9'a,9'b,10',11',11'a-hexadecahydro-7'-hydroxy-7,9'a,11'a-trimethyl-6,8-dioxo-1'-[(1R,2E,4R)-1,4,5-trimethyl-2-hexenyl]spiro[1H-2-benzopyran-5(6H),4'-[4H]indeno[6,7,1-mna]anthracen]-7-ylester (9CI)
Dispiro[cyclopropane-1,2'(10'H)-phenanthrene-10',2''-phenanthro[3,4-d][1,3]dioxole]-1',4',6'',9'(3'H,8''H)-tetrone,3',6'-bis(acetyloxy)-4'b,5',6',7',8',8'a,9'',10'',11'',11''a-decahydro-5'',7''-dihydroxy-2,4'b,8',8',8'',8'',11''a-heptamethyl-4''-(1-methylethyl)-,(1'S,2S,2''R,3'R,4'bS,6'S,8'aS)- (9CI)
7-Azabicyclo[2.2.1]heptane,7,7'-(1,2-dioxo-1,2-ethanediyl)bis[2-(6-chloro-3-pyridinyl)-,(1R,1'R,2R,2'R,4S,4'S)-rel-
Dispiro[cyclopropane-1,2'(10'H)-phenanthrene-10',2''-phenanthro[3,4-d][1,3]dioxole]-1',4',6'',9'(3'H,8''H)-tetrone,3',6'-bis(acetyloxy)-4'b,5',6',7',8',8'a,9'',10'',11'',11''a-decahydro-5'',7''-dihydroxy-2,4'b,8',8',8'',8'',11''a-heptamethyl-4''-(1-methylethyl)-,(1'S,2S,2''S,3'R,4'bS,6'S,8'aS)- (9CI)
N-(1-Methyl-2-(4-ethylpiperazino)ethyl)aniline dioxalate
N-(1-Methyl-2-(4-benzylpiperazino)ethyl)aniline dioxalate
Spiro[furan-3(2H),1'(2'H)-phenanthren]-5(4H)- one,2'-[(1R,2S)-2-(acetyloxy)-1-methyl-3- [(2S,4R)-tetrahydro-4-methyl-5-oxo-2- furanyl]propyl]-3',4',4'a,4'b,5',6',7',8',8'a,9',10',- 10'a-dodecahydro-7'-hydroxy-4'b,8',8',10'atetramethyl-,(1'S,2'R,4'aR,4'bR,7'S,8'aR,- 10'aR)-
1/C12H9NO/c14-9-11-3-1-2-4-12(11)10-5-7-13-8-6-10/h1-9
1/C8H5BrCl2/c9-7-3-1-6(2-4-7)5-8(10)11/h1-5
Isoquinolinium,2,2'-[[(4E)-1,8-dioxo-4-octene-1,8-diyl]bis(oxy-3,1-propanediyl)]bis[1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-,(1R,1'R)-
4-Thiazolidinecarboxylic acid,3-[10-(4,5-dimethoxy-2-methyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-1-oxodecyl]-, (R)-
Spiro[bicyclo[2.2.2]oct-7-ene-2,2'-[4,7]ethano[1,- 3]benzodioxole]-5,8'-dicarboxylic acid,6',8-bis[(1E)-3-[(1R)-1-carboxy-2-(3,- 4-dihydroxyphenyl)ethoxy]-3-oxo-1- propenyl]-6,9'-bis(3,4-dihydroxyphenyl)-3'a,- 4',7',7'a-tetrahydro-7'a-hydroxy-3-oxo-,(1R,2S,3'aR,4R,4'R,5R,6S,7'R,7'aS,8'R,9'S)-
2-Ethoxy-6-(N-(1-methyl-2-(4-phenethylpiperazino)ethyl)propionamide)benzothiazole dioxalate
4(S)-[3-[2-[3(S)-[1(S)-Phenylethylaminomethyl]-1-pyrrolidinyl]ethyl]-1H-indol-5-ylmethyl]oxazolidin-2-one dioxalate
2,2,2-trichloroethyl (1R,2R,5S)-10-(benzyloxy)-3-((R)-1-(6-(benzyloxy)-7-methylbenzo[d][1,3]dioxol-4-yl)-2-hydroxyethyl)-2-(((tert-butyldimethylsilyl)oxy)methyl)-9-methoxy-8-methyl-4-oxo-1,2,3,4,5,6-hexahydro-1,5-epiminobenzo[d]azocine-11-carboxylate
1/C7H3Cl3O/c8-5-1-2-6(9)7(10)4(5)3-11/h1-3
1/C11H7ClO2/c12-9-3-1-2-8(6-9)11-5-4-10(7-13)14-11/h1-7
6-Isoquinolinol,1,2,3,4-tetrahydro-7-methoxy-1-[[4-methoxy-3-[4-[[(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl]methyl]phenoxy]phenyl]methyl]-2-methyl-,(1R)-
6-Isoquinolinol,1,2,3,4-tetrahydro-1-[[4-hydroxy-3-[4-[[(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl]methyl]phenoxy]phenyl]methyl]-7-methoxy-2-methyl-,(1R)-